Stemline Therapeutics is Biotechnology in United States that focus on Stemline Therapeutics Inc business. Founded in 2003. They cover business area such as Stemline Therapeutics Inc, therapeutic, oncology indication, unmet medical need, its pipeline product candidate, felezonexor, (a kinase inhibitor, an immunotherapy, its clinical stage program, its intellectual property portfolio, additional product and technology right.
2003
( 21 years old in 2024 )
Stemline Therapeutics Inc
-
750 Lexington Avenue
11th Floor
New York, NY 10022
United States
Private
Stemline Therapeutics Inctherapeuticoncology indicationunmet medical needits pipeline product candidatefelezonexor(a kinase inhibitoran immunotherapyits clinical stage programits intellectual property portfolioadditional product and technology right
* We use standard office opening hours in near Stemline Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stemline Therapeutics is Biotechnology business from United States that founded in 2003 (21 years old in 2024), Stemline Therapeutics business is focusing on Stemline Therapeutics Inc.
Stemline Therapeutics headquarter office and corporate office address is located in 750 Lexington Avenue 11th Floor New York, NY 10022 United States.
Stemline Therapeutics was founded in United States.
In 2024, Stemline Therapeutics is currently focus on Stemline Therapeutics Inc sector.
Above is snippet of Google Trends for "Stemline Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stemline Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
